Results 71 to 80 of about 785,500 (213)

Invasive pulmonary aspergillosis with brain dissemination in an immunocompetent host

open access: yes, 2021
Invasive aspergillosis is an uncommon infection, which is mainly seen among immunocompromised patients. In recent years, cases of aspergillosis involving immunocompetent hosts are increasingly being reported.
Mehta, Nikhil   +9 more
core   +1 more source

Disseminated cerebral aspergillosis complicated by thrombotic microangiopathy

open access: yesMedical Mycology Case Reports, 2019
Invasive aspergillosis (IA) is a serious condition that can affect almost any organ. Cerebral aspergillosis itself is rapidly fatal without treatment. We report a case of disseminated cerebral IA in a patient exposed to cyclophosphamide, rituximab and ...
Robynn Lester   +2 more
doaj   +1 more source

Rhino‐Orbital Mucormycosis in an Immunocompetent Adult: A Case Report Emphasizing Diagnostic and Therapeutic Challenges

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Rhino‐orbital mucormycosis can present aggressively in immunocompetent adults, often with atypical initial symptoms that lead to misdiagnosis and dangerous delays. A high index of suspicion is paramount when facing a rapidly progressive orbital infection unresponsive to conventional therapy.
Seyed Mohammad Mousavi   +5 more
wiley   +1 more source

Invasive aspergillosis in a patient with end stage renal disease

open access: yes, 2017
Invasive aspergillosis caused by A. Fumigatus, almost occurs in immunocompromised hosts and has a poor prognosis. We report a case of invasive Aspergillosis in a 15-year-old boy with ESRD.
ALPAY, HARİKA   +8 more
core   +1 more source

Interpretable Machine Learning Model for Fungal Infection Prediction: A Real‐World Study

open access: yesHealth Care Science, Volume 5, Issue 5, Page 473-486, October 2026.
Our study successfully developed and validated a machine learning model based on large‐scale electronic health record data to predict the risk of fungal infections in hospitalized patients. Through a Streamlit‐powered web platform, the model was seamlessly embedded into clinical workflows, completing the full pipeline from model construction to real ...
Jinru Yang   +5 more
wiley   +1 more source

Therapeutic Outcome in Invasive Aspergillosis [PDF]

open access: yesClinical Infectious Diseases, 1996
A review of series of > or = 4 cases of invasive aspergillosis (total, 1,223 cases) was undertaken to establish the crude mortality and rate of response to therapy with amphotericin B in the major at-risk host groups. In association with pulmonary, sinus, and cerebral aspergillosis in immunocompromised patients, the crude mortality rates were 86%, 66%,
openaire   +3 more sources

New clinical presentations of invasive aspergillosis in non-conventional hosts

open access: yes, 2004
Infections by Aspergillus spp. are most typically associated with invasive pulmonary aspergillosis. However, an increasing number of reports deal with unusual manifestations of invasive aspergillosis.
Paterson, D. L., D.L. Paterson
core   +1 more source

Aspergillus PCR in Bronchoalveolar Lavage Fluid for the Diagnosis and Prognosis of Aspergillosis in Patients With Hematological and Non-hematological Conditions

open access: yesFrontiers in Microbiology, 2018
Objectives: We evaluated the usefulness of an Aspergillus fumigatus quantitative PCR assay performed in bronchoalveolar lavage fluid (BAL) for the diagnosis and prognosis of both invasive and non-invasive aspergillosis.Methods: This 4-year retrospective ...
Sébastien Imbert   +12 more
doaj   +1 more source

Mixed Invasive Aspergillus–Mucorales Pulmonary Coinfection in a Diabetic Patient: An Uncommon Dual Fungal Pneumonia and Literature Review

open access: yesRespirology Case Reports, Volume 14, Issue 10, October 2026.
Our case describes a rare lung co‐infection caused by Aspergillus and Mucorales in a 61‐year‐old man with uncontrolled diabetes and chronic kidney disease. The diagnosis was made by BAL PCR and biopsy. Despite antifungal treatment, the patient worsened and died.
Vinay Venugopal   +7 more
wiley   +1 more source

Treatment of invasive aspergillosis with itraconazole

open access: yes, 1989
PURPOSE: Invasive aspergillosis in the immunocompromised host is one of the most difficult therapeutic problems. Itraconazole, a new oral triazole, is inhibitory as well as fungicidal against Aspergillus species in vitro. It is active against Aspergillus
Stevens, D.A.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy